“…Comparing embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs) are an attractive source of stem cell therapy that does not involve ethical concerns or tumorigenesis possibilities. MSCs, which are typically isolated from bone marrow and fat tissues, have a good ability to differentiate into adipocytes, osteoblasts, and chondrocytes ( Belka et al, 2019 ; Higuchi et al, 2019 ; Tsai et al, 2019 ; Albashari et al, 2020 ; Pan et al, 2020 ; Tan et al, 2020 ; Xing et al, 2020 ; Yang J. et al, 2020 ; El-Rashidy et al, 2021 ; Mohammed et al, 2021 ; Rozila et al, 2021 ) and show an ability to differentiate into not only these three types of cells but also ectoderm- or endoderm-derived cells ( Georgiou et al, 2015 ; Andrzejewska et al, 2019 ; Han et al, 2021 ; He et al, 2020 ; Luo et al, 2021a ; Luo et al, 2021b ; Van Rensburg et al, 2021 ; Wu et al, 2021 ; Zhu et al, 2021a ). For example, 5-azacytidine in cell culture medium induces MSC differentiation into cardiomyocytes and myoblasts ( Xu et al, 2004 ).…”